Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px
Collaboration › Details

NanoString–JPMorgan Chase: investor conference, 202301 supply service NanoString presents at JP Morgan Healthcare Conference 2023


Period Period 2023-01-11
Region Region San Francisco, CA
  Country United States (USA)
Organisations Partner, 1st NanoString Technologies Inc. (Nasdaq: NSTG)
  Partner, 2nd J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco
  Product 2 nCounter™ Analysis System
Persons Person Gray, Brad (NanoString Technologies 201006– CEO before Genzyme + McKinsey healthcare practice)
  Person 2 Farrell, Doug (NanoString Technologies 202212 VP IR + Corporate Communications)

NanoString Technologies, Inc.. (12/22/22). "Press Release: NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference". Seattle, WA.

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference.

Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, January 11th, 2023, at 3:00pm PT. Interested parties can access the live webcast with accompanying slides from the investor section of the company’s website at The webcast replay will be available one hour after the conclusion of the live presentation and archived for 60 days.

About NanoString Technologies, Inc.

NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler, cited in more than 190 peer-reviewed publications, is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics from one FFPE slide. The CosMx™ Spatial Molecular Imager is an FFPE-compatible, single-cell imaging platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMx™ Spatial Informatics Platform is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. At the foundation of our research tools is our nCounter® Analysis System, cited in more than 6,500 peer-reviewed publications, which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. For more information, visit

For more information, please visit

NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.

Doug Farrell
Vice President, Investor Relations & Corporate Communications
Phone: 206-602-1768

Record changed: 2022-12-23


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for NanoString Technologies Inc. (Nasdaq: NSTG)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top